Capital Fund Management (CFM)’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.34M | Buy |
60,763
+47,738
| +367% | +$4.98M | 0.02% | 326 |
|
2025
Q1 | $1.52M | Buy |
+13,025
| New | +$1.52M | ﹤0.01% | 599 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 666 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 625 |
|
2023
Q1 | – | Sell |
-19,283
| Closed | -$1.49M | – | 580 |
|
2022
Q4 | $1.49M | Buy |
+19,283
| New | +$1.49M | 0.01% | 391 |
|
2022
Q3 | – | Sell |
-13,133
| Closed | -$503K | – | 580 |
|
2022
Q2 | $503K | Sell |
13,133
-19,045
| -59% | -$729K | ﹤0.01% | 544 |
|
2022
Q1 | $1.33M | Buy |
+32,178
| New | +$1.33M | 0.01% | 434 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 592 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 545 |
|